Chemoinformaics analysis of 5,8,11,14-Eicosatetraenoic acid, methyl ester, (all-Z)-
| Molecular Weight | 318.501 | nRot | 14 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 5 |
| Exact Molecular Weight | 318.256 | nRing | 0 |
| Solubility: LogS | -3.043 | nHRing | 0 |
| Solubility: LogP | 3.107 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 59.345 |
| nHD | 0 | BPOL | 36.713 |
| QED | 0.213 |
| Synth | 2.772 |
| Natural Product Likeliness | 0.92 |
| NR-PPAR-gamma | 0.668 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.037 |
| CACO-2 | -4.94 |
| MDCK | 0.000138531 |
| BBB | 0.104 |
| PPB | 0.987636 |
| VDSS | 2.679 |
| FU | 0.0141248 |
| CYP1A2-inh | 0.685 |
| CYP1A2-sub | 0.894 |
| CYP2c19-inh | 0.582 |
| CYP2c19-sub | 0.555 |
| CYP2c9-inh | 0.635 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.789 |
| CYP2d6-sub | 0.943 |
| CYP3a4-inh | 0.916 |
| CYP3a4-sub | 0.154 |
| CL | 4.033 |
| T12 | 0.929 |
| hERG | 0.118 |
| Ames | 0.958 |
| ROA | 0.004 |
| SkinSen | 0.965 |
| Carcinogencity | 0.795 |
| EI | 0.099 |
| Respiratory | 0.818 |
| NR-Aromatase | 0.104 |
| Antiviral | No |
| Prediction | 0.574194 |